Page last updated: 2024-08-23

phenyl acetate and Protein Aggregation, Pathological

phenyl acetate has been researched along with Protein Aggregation, Pathological in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bucciantini, M; Cesaro, S; Leri, M; Palazzi, L; Polverino de Laureto, P; Stefani, M1
Dadashpour, S; Emami, S; Irannejad, H; Ozadali, K; Tuylu Kucukkilinc, T; Unsal Tan, O1

Other Studies

2 other study(ies) available for phenyl acetate and Protein Aggregation, Pathological

ArticleYear
Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
    Biochemical pharmacology, 2020, Volume: 173

    Topics: Acetates; alpha-Synuclein; Antioxidants; Antiparkinson Agents; Cell Line, Tumor; Cell Survival; Cyclopentane Monoterpenes; Humans; Levodopa; Molecular Structure; Parkinson Disease; Phenylethyl Alcohol; Protein Aggregation, Pathological; Protein Binding; Protein Conformation; Proteolysis; Pyrans

2020
Design, synthesis and in vitro study of 5,6-diaryl-1,2,4-triazine-3-ylthioacetate derivatives as COX-2 and β-amyloid aggregation inhibitors.
    Archiv der Pharmazie, 2015, Volume: 348, Issue:3

    Topics: Acetates; Alzheimer Disease; Amyloid beta-Peptides; Blood-Brain Barrier; Cyclooxygenase 2 Inhibitors; Drug Design; Molecular Docking Simulation; Molecular Structure; Permeability; Plaque, Amyloid; Protein Aggregation, Pathological; Protein Stability; Structure-Activity Relationship; Triazines

2015